2-MeO-E2, which acts as a potential antitumor agent in several types of cancers [29,30], blocks cell growth and induces apoptosis in thyroid carcinoma cells by activating the p38 mitogen-activated protein kinase [31]. This evidence concerns the gene MAPK14 and thyroid gland carcinoma.